Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy Germany
Research
Date range: 1 April 2021 - 31 March 2022
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy published between 1 April 2021 - 31 March 2022 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 9 | 0.48 |
Outputs by subject (Share)
| Subject | Count | Share |
|---|---|---|
| Life Sciences | 7 | 0.44 |
| Chemistry | 3 | 0.05 |
Share output for the past 5 years
| 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| 1.44 | 1.09 | 0.85 | 0.79 | 1.45 |
Collaboration
Date range: 1 April 2021 - 31 March 2022
International vs. domestic collaboration by Share
- 77.37% Domestic
- 22.63% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy by Share (21 total)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and Goethe University Frankfurt (GU)
(3.02)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and Max Planck Society
(1.46)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and Helmholtz Association of German Research Centres
(0.93)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and University of Freiburg (Uni Freiburg)
(0.72)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and Frankfurt Cancer Institute (FCI)
(0.67)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and University of Göttingen
(0.52)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and Paul-Ehrlich-Institut (PEI)
(0.38)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and University of Tübingen (Uni Tübingen)
(0.34)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and Technical University of Darmstadt (TU Darmstadt)
(0.33)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and Heidelberg University (Uni Heidelberg)
(0.27)
Top 10 international collaborators with Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy by Share (40 total)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and National Institutes of Health (NIH)
(0.49)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and University of Cambridge
(0.41)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and New York University (NYU)
(0.20)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and Thermo Fisher Scientific Inc.
(0.18)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and Structural Genomics Consortium (SGC)
(0.12)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and Swiss Federal Institute of Technology Zurich (ETH Zurich)
(0.12)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and Marmara University
(0.09)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and Singapore Health Services Pte. Ltd. (SingHealth)
(0.09)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and Regeneron Pharmaceuticals, Inc.
(0.08)
-
Georg-Speyer-Haus - Institute for Tumor Biology and Experimental Therapy and Teesside University
(0.08)
Relationships
Affiliated joint institutions and consortia
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.